Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Vitone, Francesca ^a   Gibellini, Davide ^a   Schiavone, Pasqua ^a   D'Antuono, Antonietta ^a   Gianni, Lorenzo ^b   Bon, Isabella ^a   Re, Maria Carla ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ospedale Infermi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; PROVIRUS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS DETECTION; VIRUS LOAD; WESTERN BLOTTING;

AFRICA; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA, VIRAL; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; POLYMERASE CHAIN REACTION; PREVALENCE; PROVIRUSES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 33646201139     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-41     Document Type: Article

References (48)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980, 77:7415-7419.
2. Blattner WA, Takatsuki K, Gallo RC: Human T-cell leukemia-lymphoma virus and adult T-cell leukemia. JAMA 1983, 250:1074-1080.
3. Manns A, Hisada M, La Grenade L: Human T-lymphotropic virus type I infection. Lancet 1999, 353:1951-1958.
4. Nicot C: Current views in HTLV-I-associated adult T-cell leukemia/ lymphoma. Am J Hematol 2005,78:232-239.
5. Bangham CR, Hall SE, Jeffery KJ, Vine AM, Witkover A, Nowak MA, Wodarz D, Usuku K, Osame M: Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I. Philos Trans R Soc Lond B Biol Sci 1999, 354:691-700.
6. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410.
7. Zaninovic V: On the etiology of tropical spastic paraparesis and human T-cell lymphotropic virus-I-associated myelopathy. Int J Infect Dis 1999, 3:168-176.
8. Taylor GP: Pathogenesis and treatment of HTLV-I associated myelopathy. Sex Transm Infect 1998, 74:316-22.
9. Taylor GP: The human T-lymphotropic viruses: bench and bedside progress. Virus Res 2001, 78:1-4.
10. Taylor GP, Bodeus M, Courtois F, Pauli G, Del Mistro A, Machuca A, Padua E, Andersson S, Goubau P, Chieco-Bianchi L, Soriano V, Coste J, Ades AE, Weber JN: The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women. J Acquir Immune Defic Syndr 2005, 38:104-109.
11. Furnia A, Lal R, Maloney E, Wiktor S, Pate E, Rudolph D, Waters D, Blattner W, Manns A: Estimating the time of HTLV-I infection following mother-to-child transmission in a breast-feeding population in Jamaica. J Med Virol 1999, 59:541-546.
12. Tajima K, Kamura S, Ito S, Ito M, Nagatomo M, Kinoshita K, Ikeda S: Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based co-operative study in Tsushima, Japan. Int J Cancer 1987, 40:741-746.
13. Take H, Umemoto M, Kusuhara K, Kuraya K: Transmission routes of HTLV-I: an analysis of 66 families. Jpn J Cancer Res 1993, 84:1265-1267.
14. Larson CJ, Taswell HF: Human T-cell leukemia virus type I (HTLV-I) and blood transfusion. Mayo Clin Proc 1988, 63:869-875.
15. Re MC, Furlini G, Ramazzotti E, D'Antuono A, Vignoli M, La Placa M Jr, Monari P, Zauli G, La Placa M: Human T-lymphotropic virus type I (HTLV-I) provirus-related DNA sequences in peripheral blood mononuclear cells of a patient, in the absence of a definite serological positivity. New Microbiol 1993, 16:373-379.
16. Mangano AM, Remesar M, del Pozo A, Sen L: Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. J Med Virol 2004, 74:323-327.
17. Zou S, Dodd RY, Stramer SL, Strong DM, Tissue Safety Study Group: Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 2004, 351:751-759.
18. Giuliani M, Rezza G, Lepri AC, Di Carlo A, Maini A, Crescimbeni E, Palamara G, Prignano G, Caprilli F: Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases. Sex Transm Dis 2000, 27:87-92.
19. Zehender G, Colasante C, De Maddalena C, Bernini F, Savasi V, Persico T, Merli S, Ridolfo A, Santambrogio, S, Moroni M, Galli M: High prevalence of human T-lymphotropic virus type I (HTLV-I) in immigrant male-to-female transsexual sex workers with HIV-I infection. J Med Virol 2004, 74:207-215.
20. Cooke FJ, Geretti AM, Zuckerman M: Human T-cell lymphotropic virus antibody prevalence in HIV-I-infected individuals attending a sexual health clinic in South-East London. J Med Virol 2005, 76:143-145.
21. Thorstensson R, Albert J, Andersson S: Strategies for diagnosis of HTLV-I and -II. Transfusion 2002, 42:780-791.
22. Ansaldi F, Comar M, D'Agaro P, Grainfenberghi S, Caimi L, Gargiulo F, Bruzzone B, Gasparini R, Icardi G, Perandin F, Campello C, Manca N: Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy. Eur J Epidemiol 2003, 18:583-588.
23. Menin C, Bulian P, Filippi F, Buttarello M, Casado C, Lopez-Galindez C, De Rossi A, Chieco-Bianchi L, Del Mistro A: A case of adult T cell leukemia and lymphoma in an Italian woman showing different malignant clones in tumor mass and in blood. Haematologica 2003, 88:ECR23.
24. Quiros-Roldan E, Moretti F, Torti C, Casari S, Castelli F, Beltrame A, Carosi G: HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital. Infection 2003, 31:172-173.
25. Rouet F, Meertens L, Courouble G, Herrmann-Storck C, Pabingui R, Chancerel B, Abid A. Strobel M, Mauclere P, Gessain A: Serological, epidemiological, and molecular differences between human T-Cell Lymphotropic Virus Type I(HTLV-I)-seropositive healthy carriers and persons with HTLV-I Gag Indeterminate Western Blot patterns from the caribbean. J Clin Microbiol 2001, 39:1247-53.
26. Medrano FJ, Soriano V, Calderon EJ, Rey C, Gutierrez M, Bravo R, Leal M, Gonzalez-Lahoz J, Lissen E: Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk. Eur J Clin Microbiol Infect Dis 1997, 16:249-252.
27. Calderon EJ, Rey C, Medrano FJ, Sanchez-Roman J, Soriano V, Torres Y, Ruiz M, Lissen E, Leal M: Prevalence of infection by human T-cell leukemia virus types I and II in Southern Spain. Eur J Clin Microbiol Infect Dis 1995, 14:686-690.
28. Manns A, Miley WJ, Wilks RJ, Morgan OS, Hanchard B, Wharfe G, Cranston B, Maloney E, Welles SL, Blattner WA, Waters D: Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis 1999, 180:1487-1493.
29. Albrecht B, Collins ND, Newbound GC, Ratner L, Lairmore MD: Quantification of human T-cell lymphotropic virus type I proviral load by quantitative competitive polymerase chain reaction. J Virol Methods 1998, 75:123-140.
30. Lee TH, Chafets DM, Busch MP, Murphy EL: Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol 2004, 31:275-282.
31. Folks TM, Powell D, Lightfoote M, Koenig S, Fauci AS, Benn S, Rabson A, Daugherty D, Gendelman HE, Hoggan MD: Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 1986, 164:280-90.
32. Gibellini D, Vitone F, Gori E, La Placa M, Re MC: Quantitative detection of human immunodeficiency virus type I (HIV-I) viral load by SYBR green real-time RT-PCR technique in HIV-I seropositive patients. J Virol Methods 2004, 115:183-189.
33. Gibellini D, Vitone F, Schiavone P, Ponti C, La Placa M, Re MC: Quantitative detection of human immunodeficiency virus type I (HIV-I) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. J Clin Virol 2004, 29:282-289.
34. Bohling SD, Elelitoba-Johnson KSJ: Development of PCR-based assays for the detection of chromosomal translocations using SYBR Green I. In Rapid cycle real-time PCR: methods and applications Edited by: Meuer S, Wittwer C. Nakagawara K. Berlin: Springer-Verlag, 2001:231-239.
35. Nunnari A, Russo R, Cosentino S, Cacopardo B, Celesia BM, La Rosa R, Nigro I, Saracco A, Lillo F, Varnier OE: The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy. J Acquir Immune Defic Syndr 1992, 5:211-212.
36. Mozzi F, Rebulla P, Lillo F, Varnier OE, Biadati C, Calcagno L, Melotti S, Sirchia G: HIV and HTLV infections in 1305 transfusion-dependent thalassemics in Italy. In AIDS Volume 6. The COOLEYCARE Cooperative Group; 1992:505-8.
37. Boeri E, Abecasis C, Varnier OE, Franchini G: Analysis of HTLV-I Env gene sequence from an Italian polytransfused patient: evidence for a Zairian HTLV-I in Sicily. AIDS Res Hum Retroviruses 1995, 11:649-51.
38. Ferrante P, Mancuso R, Zuffolato R, Puricelli S, Mannella E, Romano L, Zanetti A, Cattaneo F, Corraô V: Molecular analysis pf HTLV-I and HTLV-II isolates from Italian blood donors, intravenous drug users and prisoners. New Microbiol 1997, 20:93-104.
39. Lillo FB, Capiluppi B, Chiarolini A, McDermott JL, Varnier OE: First report of the presence of human T-cell lymphotropic virus I infection in Italian drug addicts. Eur J Clin Microbiol Infect Dis 1999, 18:671-672.
40. Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL, HTLV Outcomes Study Investigators: A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis 2005, 191:1490-1497.
41. Yamaguchi K, Seiki M, Yoshida M, Nishimura H, Kawano F, Takatsuki K: The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood 1984,63:1235-1240.
42. Taylor GP, Hall SE, Navarrete S, Michie CA, Davis R, Witkover AD, Rossor M, Nowak MA, Rudge P, Matutes E, Bangham CR, Weber JN: Effect of lamivudine on human T-cell leukemia virus type I (HTLV-I) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-I-associated myelopathy. J Virol 1999, 73:10289-10295.
43. Varmus HE: Form and function of retroviral proviruses. Science 1982, 216:812-20.
44. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M: Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998, 4:586-593.
45. Ono A, Ikeda E, Mochizuki M, Matsuoka M, Yamaguchi K, Sawada T, Yamane S, Tokudome S, Watanabe T: Provirus load in patients with human T-cell leukemia virus type I uveitis correlates with precedent Graves' disease and disease activities. Jpn J Cancer Res 1998, 89:608-614.
46. Yoshida M, Osame M, Kawai H, Toita M, Kuwasaki N, Nishida Y, Hiraki Y, Takahashi K, Nomura K, Sonoda S: Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 1989, 26:331-335.
47. Espy MJ, Ross TK, Teo R, Svien KA, Wold AD, Uhl R, Mitchell PS: Evaluation of LightCycler PCR for implementation of laboratory diagnosis of herpes simplex virus infections. J Clin Microbiol 2000, 38:3116-3118.
48. Waziri A, Soldan SS, Graf MD, Nagle J, Jacobson S: Characterization and sequencing of prototypic human T-lymphotropic virus type I(HTLV-I) from an HTLV-I/2 seroindeterminate patient. J Virol 2000, 74:2178-2185.